National Institutes of Health grant notices posted in 2022, now closed
735 National Institutes of Health grant notices posted on Grants.gov in 2022 that have closed, with their numbers and dates.
- RFA-MH-23-115: Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R01 Clinical Trial Optional)
- RFA-MH-23-116: Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R21 Clinical Trial Optional)
- PAR-23-049: NIDA Core "Center of Excellence" Grant Program (P30 Clinical Trial Optional)
- RFA-TR-23-001: Translational Centers for Microphysiological Systems (TraCe MPS) (U2C Clinical Trials Not Allowed)
- PAR-23-068: Limited Competition: Brain Tissue Resource Center for Alcohol Research (R28 Clinical Trial Not Allowed)
- RFA-AR-24-001: NIAMS Skin Biology and Diseases Resource-based Centers (P30 - Clinical Trial Not Allowed)
- RFA-AR-24-002: NIAMS Resource-based Centers for Bone, Muscle and Orthopaedic Research (P30 - Clinical Trial Not Allowed)
- RFA-PM-23-001: Enhancing the Use of the All of Us Research Programs Data (R21 Clinical Trial Not Allowed)
- PAR-23-081: Early and Late Stage Clinical Trials for the Spectrum of Alzheimers Disease/Alzheimers Related Dementias and Age-Related Cognitive Decline (R01 Clinical Trial Optional)
- PAR-23-083: Pilot Studies for the Spectrum of Alzheimers Disease/Alzheimers Disease-Related Dementias and Age-Related Cognitive Decline (R61 Clinical Trial Optional)
- PAR-23-075: Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data (R03 Clinical Trial Not Allowed)
- RFA-DK-22-023: Ancillary Studies to the NIDDK Inflammatory Bowel Disease Genetics Consortium (R01 Clinical Trial Not Allowed)
- RFA-AG-24-024: Understanding the Supply of Professional Dementia Care Providers and Their Decisions (U54 Clinical Trial Not Allowed)
- RFA-PM-23-002: Small Grants to Enhance the Use of the All of Us Research Programs Data (R03 Clinical Trial Not Allowed)
- RFA-CA-23-014: Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional)
- RFA-CA-23-015: Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)
- RFA-CA-23-016: Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
- RFA-CA-23-017: Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
- PAR-23-085: Genomic Community Resources (U24 Clinical Trial Not Allowed)
- PAR-23-079: Biomedical Data Repository (U24 - Clinical Trials Not Allowed)
- PAR-23-078: Biomedical Knowledgebase (U24 - Clinical Trials Not Allowed)
- RFA-AI-22-070: Autoimmunity Centers of Excellence, Basic Research Program (U19 Clinical Trial Not Allowed)
- RFA-AI-22-071: Autoimmunity Centers of Excellence, Clinical Research Program (UM1 Clinical Trial Required)
- RFA-MH-23-335: BRAIN Initiative: Brain Behavior Quantification and Synchronization (R61/R33 Clinical Trial Optional)
- PAR-23-045: Biomedical Research Facilities (C06 Clinical Trial Not Allowed)
- PAR-23-063: Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 - Clinical Trial Optional)
- RFA-DA-24-013: Mechanisms and Targets at the Intersection of HIV and Substance Use (R01 Clinical Trials Not Allowed)
- RFA-DA-24-014: Mechanisms and Targets at the Intersection of HIV and Substance Use (R21 Clinical Trials Not Allowed)
- RFA-DA-24-011: Substance Use Prevention Effectiveness Research Among Youth and Families in the Child Welfare System (R61/R33 Clinical Trial Required)
- RFA-DA-24-012: Substance Use Prevention Effectiveness Research Among Youth and Families in the Child Welfare System (R01 Clinical Trial Required)
- RFA-AT-23-009: Research Networks to Promote Multidisciplinary Mechanistic Studies on Music-Based Interventions for Pain or Alzheimers Disease and Alzheimers Disease Related Dementias (AD/ADRD) (U24 Clinical Trial Optional)
- RFA-NS-22-022: HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research (K99/R00 Independent Clinical Trial Not Allowed)
- RFA-NS-22-023: HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research (Independent Basic Experimental Studies with Humans Required)
- RFA-NS-22-024: HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research to Promote Diversity (K99/R00 Independent Basic Experimental Studies with Humans Required)
- RFA-NS-22-025: HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)
- RFA-NS-23-008: NIH StrokeNet National Data Management Center for year 2023 (U01 Clinical Trials Not Allowed)
- RFA-NS-23-009: NIH StrokeNet National Coordinating Center for year 2023 (U01 Clinical Trials Not Allowed)
- RFA-NS-23-010: NIH StrokeNet- Regional Coordinating Stroke Centers for year 2023 (U24 - Clinical Trials Not Allowed)
- PAR-23-059: National Cancer Institute Program Project Applications for the Years 2023, 2024, and 2025 (P01 Clinical Trial Optional)
- PAR-23-055: Co-infection and Cancer (R01 Clinical Trial Not Allowed)
- PAR-23-056: Co-infection and Cancer (R21 Clinical Trial Not Allowed)
- RFA-AI-22-075: Limited Competition: Resources and Workforce Development for the Regional Biocontainment Laboratories (UC7 Clinical Trial Not Allowed)
- PAR-23-050: Clinical Studies of Mental Illness (Collaborative R01) (Clinical Trial Optional)
- RFA-OD-23-003: Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Sciences (R25 Independent Clinical Trial Not Allowed)
- PAR-23-066: Research on Community Level Interventions for Firearm and Related Violence, Injury and Mortality Prevention (CLIF-VP) (UG3/UH3 Clinical Trial Required)
- RFA-AG-24-005: Interorgan Communication in Aging (U01 Clinical Trial Not Allowed)
- RFA-DA-24-010: Rapid Translation of Epidemiological Findings into Interventions to Prevent Substance Use and Addiction (R61/R33 Clinical Trial Optional)
- RFA-AT-23-008: Research Networks to Promote Multidisciplinary Mechanistic Studies on Music-Based Interventions for Pain or Alzheimers Disease and Alzheimers Disease Related Dementias (AD/ADRD) (U24 Clinical Trial Optional)
- PAR-23-067: Development of Animal Models and Related Biological Materials for Down Syndrome Research (R21 Clinical Trials Not Allowed)
- PAR-23-042: Implementation Research on Noncommunicable Disease Risk Factors among Low- and Middle-Income Country and Tribal Populations Living in City Environments (R01 Clinical Trial Optional)
- PAR-23-043: Implementation Research on Noncommunicable Disease Risk Factors among Low- and Middle-Income Country and Tribal Populations Living in City Environments (R61/R33 Clinical Trial Required)
- RFA-DK-22-012: NIDDK Investigator Award to Support Mentoring of Early Career Researchers from Diverse Backgrounds (K26 - Independent Clinical Trial Not Allowed)
- PAR-23-058: NCI Small Grants Program for Cancer Research for Years 2023, 2024, and 2025 (NCI Omnibus) (R03 Clinical Trial Optional)
- RFA-CA-23-009: Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional)
- RFA-CA-23-008: Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trials Optional)
- RFA-CA-23-003: Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- RFA-CA-23-004: Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
- RFA-CA-23-005: Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- RFA-CA-23-002: Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
- RFA-CA-23-010: Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional)
- RFA-CA-23-011: Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional)
- RFA-CA-23-006: Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional)
- RFA-CA-23-007: Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional)
- RFA-OD-23-005: NIH Research Evaluation and Commercialization Hubs (REACH) Awards (U01 Clinical Trial Optional)
- RFA-DK-22-017: NIDDK Information Network Coordinating Unit: dkNET-CU (U24 Clinical Trial Not Allowed)
- PAR-23-057: NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required)
- RFA-OD-23-002: NIH Research Evaluation and Commercialization Hubs (REACH) Awards (U01 Clinical Trial Optional)
- RFA-DK-22-027: Fostering Research With Additional Resources and Development (FORWARD) Urology Centers (P20 Clinical Trial Not Allowed)
- PAR-23-037: Multisite Clinical Research: Leveraging Network Infrastructure to Advance Research for Women, Children, Pregnant and Lactating Individuals, and Persons with Disabilities (U01 Clinical Trial Optional)
- PAR-23-036: Secondary Analysis of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21 Clinical Trial Not Allowed)
- RFA-HD-24-004: Opportunities for Advancing Limb Regeneration Research (R01 Clinical Trial Not Allowed)
- RFA-RM-23-003: Pilot Projects Enhancing Utility and Usage of Common Fund Data Sets (R03 Clinical Trial Not Allowed)
- PAR-23-038: Testing Centers for Development of Somatic Cell Genome Editing in Model Organisms (U42) (Clinical Trials Not Allowed)
- PAR-23-065: NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)
- PAR-22-256: Pragmatic Trials across the Cancer Control Continuum (UG3/UH3 Clinical Trial Required)
- PAR-23-030: Leading Equity and Diversity in the Medical Scientist Training Program (LEAD MSTP)(T32)
- RFA-AI-22-067: International Centers of Excellence for Malaria Research (U19 Clinical Trial Not Allowed)
- RFA-HD-24-006: Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 - Clinical Trial Not Allowed)
- RFA-MH-23-310: Social Drivers of Mental Illnesses in Low- and Middle-Income Countries: Mechanisms and Pathways of Interventions for Youth (R01 Clinical Trial Optional)
- PAR-23-025: Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed)
- PAR-23-026: Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed)
- PAR-23-051: Mechanistic links between diet, lipid metabolism, and tumor growth and progression (U01 Clinical Trial Not Allowed)
- PAR-23-052: Mechanistic links between diet, lipid metabolism, and tumor growth and progression (UH2 Clinical Trial Not Allowed)
- PAR-23-053: Research Infrastructure Development for Interdisciplinary Aging Studies (R61/R33 - Clinical Trial Optional)
- PAR-23-054: Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 Clinical Trial Optional)
- RFA-ES-22-010: Environmental Health Sciences Core Centers (EHSCC) (P30 Clinical Trial Optional)
- PAR-24-022: Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional)
- RFA-DK-23-002: Chronic Kidney Disease in Children Central Biochemistry Laboratory (U24 Clinical Trial Not Allowed)
- RFA-DK-23-003: Interventions that Address Structural Racism to Reduce Kidney Health Disparities Research Coordinating Center (U24 - Clinical Trial Not Allowed)
- RFA-CA-23-020: NCI Cancer Screening Research Network: ACCrual, Enrollment, and Screening Sites (ACCESS) Hub (UG1 Clinical Trial Required)
- RFA-CA-23-021: NCI Cancer Screening Research Network: Statistics and Data Management Center (UG1 Clinical Trial Required)
- RFA-CA-23-022: NCI Cancer Screening Research Network: Coordinating and Communication Center (UG1 Clinical Trial Required)
- RFA-DA-24-002: Exploratory studies to investigate mechanisms of HIV infection, replication, latency, and/or pathogenesis in the context of substance use disorders (R61/R33 - Clinical Trial Not Allowed)
- RFA-DA-23-060: HEAL Initiative - Sleep Predictors of Opioid-Use Disorder Treatment Outcomes Program: Leadership and Data Co-ordinating Center (U01 Clinical Trial Optional)
- RFA-DA-23-059: HEAL Initiative: Sleep Predictors of Opioid-Use Disorder Treatment Outcomes Program (R01 Clinical Trial Optional)
- RFA-AI-22-069: Cooperative Centers on Human Immunology (U19 Clinical Trial Optional)
- PAR-23-046: Engineering Next-Generation Human Nervous System Microphysiological Systems (R01 Clinical Trials Not Allowed)
- PAR-23-047: Engineering Next-Generation Human Nervous System Microphysiological Systems (R21 Clinical Trials Not Allowed)
- RFA-OD-22-024: Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Required)
- RFA-OD-22-025: Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Not Allowed)
- RFA-OD-22-023: Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Not Allowed)
- RFA-OD-22-026: Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Required )
- RFA-DA-23-036: Investigating the Effects of Addictive Substances on Brain Developmental Trajectories Using Innovative Scalable Methods for Quantification of Cell Identity, Lineage and Connectivity (R01 - Clinical Trial Not Allowed)
- RFA-CA-23-013: Transformative Educational Advancement and Mentoring Network (TEAM) (R25 Clinical Trial Not Allowed)
- RFA-MD-22-010: John Lewis NIMHD Research Endowment Program (S21 Clinical Trial Not Allowed)
- RFA-NS-22-069: HEAL Initiative Integrated Basic and Clinical Team-based Research in Pain(RM1 Clinical Trial Optional)
- RFA-DA-24-003: Targeting Inflammasomes in Substance Abuse and HIV (R01 Clinical Trial Not Allowed)
- RFA-DA-24-004: Targeting Inflammasomes in Substance Abuse and HIV (R21 Clinical Trial Not Allowed)
- RFA-HD-24-001: Pediatric Critical Care and Trauma Scientist Development Program (K12 Clinical Trial Optional)
- PAR-23-041: Functional Validation and/or Characterization of Genes or Variants Implicated in Substance Use Disorders (R21/R33 Clinical Trial Not Allowed)
- PA-23-044: Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement Clinical Trial Optional)
- RFA-CA-23-018: Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment: Liquid Biopsy Research Laboratories (U01 Clinical Trial Not Allowed)
- RFA-CA-23-019: Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment: Data Management and Coordinating Unit (U24 Clinical Trial Not Allowed)
- PAR-23-033: Integrated Preclinical / Clinical AIDS Vaccine Development Program (IPCAVD) (U19 Clinical Trial Not Allowed)
- PAR-22-248: HIV/AIDS Scholars Using Nonhuman Primate (NHP) Models Program (K01 Independent Clinical Trial Not Allowed)
- PAR-23-039: Development of Resources and Technologies for Enhancing Rigor, Reproducibility, and Translatability of Animal Models in Biomedical Research (R24 Clinical Trials Not Allowed)
- PAR-23-040: Development of Resources and Technologies for Enhancing Rigor, Reproducibility, and Translatability of Animal Models in Biomedical Research (R01)
- PAR-22-252: Early Stage Investigator HIV/AIDS Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed)
- PAR-22-249: Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54 Clinical Trial Optional)
- PAR-22-239: Feasibility Studies to Build Collaborative Partnerships in Cancer Research (P20 Clinical Trial Not Allowed)
- PAR-23-032: Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed)
- PAR-23-021: Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional)
- RFA-DK-22-039: Toward ElucidAting MechanismS of HIV Pathogenesis within the Mission of the NIDDK (Pathogenesis TEAMS) (R01 Clinical Trial Optional)
- RFA-ES-22-007: Utilizing Telomere Status to Reveal Molecular Mechanisms Underlying Susceptibility and Resiliency in Response to Environmental Exposures (R01 Clinical Trial Not Allowed)
- RFA-DA-24-007: Avenir Award Program for Chemistry and Pharmacology of Substance Use Disorders (DP1- Clinical Trial Not Allowed)
- PAR-23-029: NCMRR Early Career Research Award (R03 Clinical Trial Optional)
- RFA-AT-23-006: Research Networks to Promote Multidisciplinary Mechanistic Studies on Music-Based Interventions for Pain or Alzheimers Disease and Alzheimers Disease Related Dementias (AD/ADRD) (U24 Clinical Trial Optional)
- RFA-HL-24-005: Limited Competition: Small Grant Program for NHLBI K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)
- PAR-22-247: Development of Animal Models and Related Biological Materials for Down Syndrome Research (R24 Clinical Trials Not-Allowed)
- RFA-DE-23-013: AHEAD (Advancing Head and Neck Cancer Early Detection Research) (U01 Clinical Trial Not Allowed)
- RFA-OD-22-028: The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional)
- RFA-HD-24-002: Development of Novel Nonsteroidal Contraceptive Methods (R61/R33 - Clinical Trial Not Allowed)
- PAR-23-031: Dual Purpose with Dual Benefit: Research in Biomedicine and Agriculture Using Agriculturally Important Domestic Animal Species (R01)
- PAR-22-253: Limited Competition: Development and Renovation of Research Space for HIV/AIDS Research at Institutions Serving Underrepresented Populations or Located in Institutional Development Award (IDeA)-eligible States (C06)
- RFA-DA-23-030: BRAIN Initiative: Brain-Behavior Quantification and Synchronization Transformative and Integrative Models of Behavior at the Organismal Level (R34 Clinical Trial Not Allowed)
- RFA-HD-23-022: Learning Disabilities Research Centers (P50 Clinical Trial Optional)
- PAR-23-034: NLM Research Grants in Biomedical Informatics and Data Science (R01 Clinical Trial Optional)
- RFA-RM-23-001: Community Partnerships to Advance Science for Society (ComPASS): Coordination Center (U24 Clinical Trial Optional)
- RFA-DK-22-018: Human Islet Research Network (HIRN) Pancreas Knowledgebase Program (PanKbase) (U24 - Clinical Trial Not Allowed)
- RFA-AI-22-060: Immunity in Older Adults (U01 Clinical Trial Not Allowed)
- RFA-OD-22-027: Advanced Training in Artificial Intelligence for Precision Nutrition Science Research (AIPrN) Institutional Research Training Programs (T32)
- RFA-AI-22-047: Genetic Tools for Understanding Rickettsial and Related Infections (R61/R33 Clinical Trial Not Allowed)
- RFA-AI-22-068: Therapeutics for Eliminating Hepatitis B Virus cccDNA (R21/R33 Clinical Trial Not Allowed)
- PAR-22-195: INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Clinical Research Short Course (R25 Independent Clinical Trial Not Allowed)
- RFA-CA-22-053: Coordinating Center for Cannabis and Cannabinoid Use in Adult Cancer Patients During Treatment: Assessing Benefits and Harms (U24 Clinical Trial Not Allowed)
- RFA-CA-22-052: Cannabis and Cannabinoid Use in Adult Cancer Patients During Treatment: Assessing Benefits and Harms (U01 Clinical Trial Not Allowed)
- RFA-ES-22-009: Biological Basis for how Environmental Exposures Impact Risk for Psychiatric Disorders (R21 Clinical Trial Not Allowed)
- RFA-ES-22-008: Biological Basis for how Environmental Exposures Impact Risk for Psychiatric Disorders (R01 Clinical Trial Not Allowed)
- RFA-CA-22-043: Advancing Adolescent Tobacco Cessation Intervention Research (R01 Clinical Trial Required)
- RFA-CA-22-042: Advancing Adolescent Tobacco Cessation Intervention Research (R34 Clinical Trial Optional)
- RFA-AG-23-034: Mechanism-Focused Research to Promote Adherence to Healthful Behaviors to Prevent Mild Cognitive Impairment (MCI) and Alzheimers Disease (AD) and AD-Related Dementias (ADRD) (R61/R33 Clinical Trial Required)
- RFA-MH-22-291: BRAIN Initiative Cell Atlas Network (BICAN): Coordinating Unit for Biostatistics, Informatics, and Engagement (CUBIE) (U24 Clinical Trial Not Allowed)
- RFA-CA-22-051: Clinical Sites for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (UG1 Clinical Trial Required)
- RFA-MH-22-292: BRAIN Initiative Cell Atlas Network (BICAN): Specialized Collaboratory on Human, Non-human Primate, and Mouse Brain Cell Atlases (R01 Clinical Trial Not Allowed)
- RFA-MH-22-290: BRAIN Initiative Cell Atlas Network (BICAN): Comprehensive Center on Human and Non-human Primate Brain Cell Atlases (UM1 Clinical Trial Not Allowed)
- RFA-CA-22-056: Basic/Translational Research on Health Disparities in Underrepresented People Living with HIV (PLWH) and Cancer (R01 Clinical Trial Not Allowed)
- RFA-CA-22-057: Basic/Translational Research on Health Disparities in Underrepresented People Living with HIV (PLWH) and Cancer (R21 Clinical Trial Not Allowed)
- RFA-DA-23-061: NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial and/or Ethnic Populations (R01 Clinical Trial Optional)
- RFA-DA-23-062: NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial and/or Ethnic Populations (R34 Clinical Trial Optional)
- RFA-HG-22-026: Diversity Centers for Genome Research (U54 Clinical Trials Optional)
- RFA-HG-22-027: Diversity Centers for Genome Research (UG3/UH3 Clinical Trials Optional)
- PAR-22-236: Advancing Methods for Safe, Noninvasive, Real Time Assessment of Placenta Development and Function Across Pregnancy (R21 Clinical Trial Not Allowed)
- PAR-22-237: Advancing Methods for Safe, Noninvasive, Real Time Assessment of Placenta Development and Function Across Pregnancy (R01 Clinical Trial Not Allowed)
- PAR-22-241: NIAID Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)
- RFA-AI-22-059: Consortium for Design of TB Drug Regimens (UM1 Clinical Trial Not Allowed)
- RFA-DA-23-057: HEAL Initiative: HEAL Data2Action Innovation and Acceleration Projects, Phased Awards (R61/R33, Clinical Trial Optional)
- RFA-DA-23-058: HEAL Initiative: HEAL Data2Action Acceleration Projects (R33 Clinical Trial Not Allowed)
- RFA-NS-22-030: Data Coordinating Center for the Network of Excellence in Neuroscience Clinical Trials (NEXT - DCC) (U01 Clinical Trial Not Allowed)
- RFA-NS-22-031: Clinical Research Sites for the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT sites) (U24 Clinical Trial Not Allowed)
- RFA-DA-23-039: BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed)
- RFA-NS-22-029: Clinical Coordinating Center for the Network of Excellence in Neuroscience Clinical Trials (NEXT - CCC) (U01 Clinical Trial Not Allowed)
- RFA-DA-23-035: Large Scale Integrated Mapping and Molecular Profiling of Cell Ensembles and/or Cell-Types Mediating Opioid Action in the Rodent Brain (R01 - Clinical Trial Not Allowed)
- RFA-TR-22-032: Botulinum Toxin Potency Assay using Tissue Chips (BoT PATCh) (U43/U44 - Clinical Trail Not Allowed)
- RFA-MH-22-270: Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional)
- RFA-MH-22-271: Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)
- RFA-TR-22-031: Botulinum Toxin Potency Assay using Tissue Chips (BoT PATCh) (UT1, UT2 Clinical Trail Not Allowed)
- RFA-NR-23-001: HEAL Initiative: Prevention and Management of Chronic Pain in Rural Populations (UG3/UH3, Clinical Trials Required)
- PAR-22-254: Limited Competition: IDeA Regional Entrepreneurship Development (I-RED) Program (STTR) (UT2 Clinical Trial Not Allowed)
- RFA-HG-22-021: The NHGRI Genomic Data Science Analysis, Visualization, and Informatics Lab-space Clinical Resource (ACR) (U24 Clinical Trial Not Allowed)
- RFA-CA-22-036: NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required)
- RFA-NS-23-006: HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 Clinical Trial Not Allowed)
- RFA-NS-23-007: HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed)
- RFA-CA-22-035: NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed)
- RFA-CA-22-037: NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required)
- PAR-22-250: Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 - Clinical Trial Optional)
- RFA-HG-22-020: Limited Competition: The NHGRI Genomic Data Science Analysis, Visualization, and Informatics Lab-space (AnVIL) (U24 Clinical Trial Not Allowed)
- PAR-22-225: NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)
- RFA-CA-22-055: Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Centers (U54 Clinical Trial Not Allowed)
- PAR-22-129: Limited Competition: Small Grant Program for NIDDK K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)
- PAR-22-204: Development of Animal Models and Related Materials for HIV/AIDS Research (R24 Clinical Trials Not Allowed)
- RFA-HD-23-023: Pediatric Clinical Pharmacology Research Career Development Award (K12 Clinical Trial Not Allowed)
- PAR-22-231: NINR Areas of Emphasis for Research to Optimize Health and Advance Health for All (R21 Clinical Trial Optional)
- RFA-OD-22-013: Resource-Related Research Projects for Development of Animal Models and Related Materials (R24 Clinical Trials Not-Allowed)
- PAR-22-230: NINR Areas of Emphasis for Research to Optimize Health and Advance Health for All (R01 Clinical Trial Optional)
- PAR-22-243: Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional)
- PAR-22-242: Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed)
- RFA-DA-23-037: NIH Blueprint for Neuroscience Research: Computational Training in Neuroscience and Behavior (T90/R90 - Clinical Trial Not Allowed)
- RFA-HG-22-008: Multi-Omics for Health and Disease - Disease Study Sites (U01 Clinical Trial Optional)
- RFA-HG-22-010: Multi-Omics for Health and Disease - Data Analysis and Coordination Center (U01 Clinical Trial Not Allowed)
- RFA-HG-22-009: Multi-Omics for Health and Disease - 'Omics Production Centers (U01 Clinical Trial Not Allowed)
- RFA-HD-23-003: Elucidation and Validation of the role of Transporters in the Placenta, Lactating Mammary Gland, Developing Gut, and Blood Brain Barrier (UC2 Clinical Trial Not Allowed)
- PAR-22-233: Time-Sensitive Opportunities for Health Research (R61/R33 Clinical Trial Not Allowed)
- PAR-22-200: Development of Medications to Prevent and Treat Opioid and/or Stimulant Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)
- RFA-CA-22-050: NCI Cancer Moonshot Scholars Diversity Program (CMSDP) (R01 Clinical Trial Optional)
- RFA-DK-22-020: Clinical, Behavioral, and Physiological Studies of Open- and Closed-loop Platforms: Toward Personalized, Fully Automated, Accessible Systems (R01 Clinical Trial Required)
- RFA-AG-23-018: Understanding the Supply of Professional Dementia Care Providers and Their Decisions (U54 Clinical Trial Not Allowed)
- PAR-22-202: Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)
- RFA-MH-22-245: BRAIN Initiative: Engineering and optimization of molecular technologies for functional dissection of neural circuits (UM1 Clinical Trial Not Allowed)
- RFA-ES-22-005: Centers for Oceans and Human Health 4: Impacts of Climate Change on Oceans and Great Lakes (COHH4) (P01 Clinal Trial Optional)
- RFA-OD-22-016: Environmental influences on Child Health Outcomes (ECHO) Laboratory Core (U24) Clinical Trial Not Allowed
- RFA-OD-22-017: Open Competition: Environmental influences on Child Health Outcomes (ECHO) Pregnancy Cohort Study Sites. Clinical Trial Not Allowed (UG3/UH3)
- RFA-OD-22-019: Limited Competition: Environmental influences on Child Health Outcomes (ECHO) Cohort Study Sites for Pediatric Follow Up. Clinical Trial Not Allowed (UG3/UH3)
- RFA-OD-22-021: Environmental influences on Child Health Outcomes (ECHO) Coordinating Center (U2C) (Clinical Trial Not Allowed)
- RFA-OD-22-022: Environmental influences on Child Health Outcomes (ECHO) Data Analysis Center (U24) Clinical Trial Not Allowed
- RFA-OD-22-018: Limited Competition: Environmental influences on Child Health Outcomes (ECHO) Pregnancy and Pediatric Cohort Study Sites. Clinical Trial Not Allowed (UG3/UH3)
- RFA-OD-22-020: Environmental influences on Child Health Outcomes (ECHO) Measurement Core (U24) Clinical Trial Not Allowed
- RFA-HD-23-030: HEAL Initiative: Opioid Exposure and Effects on Placenta Function, Brain Development, and Neurodevelopmental Outcomes (R01 Clinical Trial Not Allowed)
- RFA-HD-23-031: HEAL Initiative: Opioid Exposure and Effects on Placenta Function, Brain Development, and Neurodevelopmental Outcomes (R21 Clinical Trial Not Allowed)
- RFA-HD-23-033: HEAL Initiative: Opioid Exposure and Effects on Placenta Function, Brain Development, and Neurodevelopmental Outcomes (R21 Basic Experimental Studies with Humans Required)
- RFA-HD-23-032: HEAL Initiative: Opioid Exposure and Effects on Placenta Function, Brain Development, and Neurodevelopmental Outcomes (R01 Basic Experimental Studies with Humans Required)
- PAR-23-027: CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed)
- PAR-22-234: The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed)
- PAR-22-235: Blood Brain Barrier Response to Antibodies Targeting Beta-Amyloid (R01 - Clinical Trial Not Allowed)
- RFA-DK-22-013: Drug Induced Liver Injury Network (DILIN) Clinical Centers (U01 - Clinical Trial Optional)
- RFA-CA-22-029: Cancer Adoptive Cellular Therapy Network (Can-ACT) for Pediatric Cancers (UG3/UH3 Clinical Trial Required)
- RFA-CA-22-030: Cancer Adoptive Cellular Therapy Network (Can-ACT) Coordinating Center (U24 Clinical Trial Not Allowed)
- PAR-22-224: NICHD Research Education Programs (R25 Clinical Trial Not Allowed)
- RFA-DK-22-507: Limited Competition for the Continuation of the APOL1 Long-term Kidney Transplantation Outcomes Network Scientific and Data Research Center (APOLLO SDRC) (Collaborative U01 - Clinical Trial Not Allowed)
- RFA-DK-22-508: Limited Competition for the Continuation of the Drug Induced Liver Injury Network Data Coordinating Center (DILIN) (U01 - Clinical Trial Not Allowed)
- RFA-NS-23-017: Optimization of Genome Editing Therapeutics for Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD) (U01 - Clinical Trials Not Allowed)
- RFA-CA-22-028: Cancer Adoptive Cellular Therapy Network (Can-ACT) for Adult Cancers (UG3/UH3 Clinical Trial Required)
- PAR-23-024: Catalyst Award for Early-Stage Investigators (ESIs) Pursuing Research on HIV Comorbidities, Coinfections, and Complications (DP1- Clinical Trial Optional)
- PAR-22-227: NIA Research and Entrepreneurial Development Immersion (REDI): Mentored Entrepreneurial Career Development Award (K01 Clinical Trial Not Allowed)
- PAR-22-226: NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurship Enhancement Award (R25 Independent Clinical Trial Not Allowed)
- RFA-EB-22-002: HEAL Initiative: Translational Development of Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed)
- RFA-DK-22-506: Limited Competition for the Continuation of the APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Centers (Collaborative U01 - Clinical Trial Not Allowed)
- RFA-HD-23-025: Physiomimetics and Organoids for Reproductive Health (R21 Clinical Trial Not Allowed)
- RFA-AI-22-055: Maintaining Immunity after Immunization (U01 Clinical Trial Not Allowed)
- RFA-HD-23-024: Physiomimetics and Organoids for Reproductive Health (R01 Clinical Trial Not Allowed)
- RFA-AT-23-007: REsearch Across Complementary and Integrative Health Institutions (REACH) Virtual Resource Centers (U24 Clinical Trial Not Allowed)
- RFA-CA-22-054: The Early Detection Research Network: Clinical Validation Centers (U01 Clinical Trial Optional)
- RFA-HD-23-018: MPRINT Translational Research Resource Platform (TRRP) (U24 Clinical Trial Not Allowed)
- RFA-DE-23-012: Practice-Based Research Integrating Multidisciplinary Experiences in Dental Schools (PRIMED) (U01 Clinical Trial Not Allowed)
- PAR-22-229: Laboratory of Developmental Biology (R24 Clinical Trial Not Allowed)
- RFA-CA-22-041: The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed)
- RFA-AT-23-003: Fostering Mental, Emotional, and Behavioral (MEB) Health Among Children in School Settings: Opportunities for Multisite Trials of Complementary and Integrative Health Interventions (Clinical Trial Optional)
- RFA-DA-23-050: HEAL Initiative: Development and validation of virtual assessments to study children and caregivers in their natural environment (R01- Clinical Trial Not Allowed)
- RFA-DA-23-055: HEAL Initiative: Development and validation of virtual assessments to study children and caregivers in their natural environment (R01- Basic Experimental Studies with Humans Required)
- RFA-DA-23-056: Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)
- PAR-22-228: Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (U01 Clinical Trial Optional)
- RFA-NS-22-061: Training Award to Promote Cross-Training in the Fields of Traumatic Brain Injury (TBI) as a Risk Factor for Alzheimers Disease/Alzheimers Disease Related Dementias (AD/ADRD) (K18 Clinical Trial Not Allowed)
- PAR-23-022: Javits Neuroscience Investigator Award Extension Request (Type 4 Clinical Trial Optional)
- RFA-CA-22-032: Consortium on Translational Research in Early Detection of Liver Cancer: Data Management and Coordinating Center (U24 Clinical Trial Not Allowed)
- RFA-CA-22-046: Radiation Oncology-Biology Integration Network (ROBIN) Centers (U54 Clinical Trial Required)
- RFA-AT-23-005: Research Resource Center to Build an Open-Access Repository and Database for Anatomical and Physiological Correlates of Acupoints (U24, Clinical Trial Optional)
- RFA-CA-22-031: Consortium on Translational Research in Early Detection of Liver Cancer: Translational Research Centers (U01 Clinical Trial Optional)
- RFA-HG-22-019: Molecular Phenotypes of Null Alleles in Cells (MorPhiC) Phase I: Data Analysis and Validation Centers (U01 Clinical trials not allowed)
- RFA-HD-23-036: Maternal Health Research Centers of Excellence Data Innovation and Coordinating Hub/Resource Center (U24 Clinical Trial Not Allowed)
- RFA-HD-23-035: Maternal Health Research Centers of Excellence (U54 Clinical Trial Optional)
- RFA-HD-23-037: Maternal Health Research Centers of Excellence Implementation Science Hub/Resource Center (U24 Clinical Trial Optional)
- PAR-22-205: NIAMS Clinical Trial Planning Grant (R34) - Clinical Trial Not Allowed
- RFA-HD-23-012: Reproductive Scientist Development Program (RSDP) (K12 Clinical Trial Not Allowed)
- PAR-22-221: AD/ADRD, Adverse Childhood Experiences, and Social Determinants of Health Ancillary Studies of Existing Longitudinal Cohorts (R01 - Clinical Trial Not Allowed)
- RFA-HD-23-034: Pediatric Scientist Development Program (PDSP) (K12 Clinical Trial Not Allowed)
- RFA-NS-22-062: Connecting Machine Readable Digital Human AD/ADRD Neuropathological Library Platforms for Advanced Analytics (U24 Clinical Trial Not Allowed)
- RFA-NS-22-070: HEAL Initiative: Development and Validation of Non-Rodent Mammalian Models of Pain(R01 Clinical Trial Not Allowed)
- RFA-DA-23-032: NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research at Minority Serving Institutions (R01 Clinical Trial Optional)
- RFA-AI-22-054: Allergy and Asthma Statistical and Clinical Coordinating Center (AA-SCCC) (U01 Clinical Trial Not Allowed)
- RFA-AI-22-058: National Institute of Allergy and Infectious Diseases (NIAID) Clinical Data and Safety Management Center (CDSMC) (U01 Clinical Trial Not Allowed)
- RFA-AT-23-004: REsearch Across Complementary and Integrative Health Institutions (REACH) Virtual Resource Centers (U24 Clinical Trial Not Allowed)
- RFA-DA-23-013: NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research (R01 Clinical Trial Optional)
- RFA-DA-23-023: NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial/Ethnic Populations (R01 Clinical Trial Optional)
- RFA-DA-23-024: NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial/Ethnic Populations (R34 Clinical Trial Optional)
- RFA-DA-23-025: NIDA REI: Coordination Center to Support Racial Equity and Substance Use Disparities Research (U24 Clinical Trial Not Allowed)
- RFA-DA-23-026: NIDA REI: Racial Equity Visionary Award Program for Research on Substance Use and Racial Equity (DP1 Clinical Trial Optional)
- RFA-DA-23-028: NIDA REI: Research on Neurocognitive Mechanisms Underlying the Impact of Structural Racism on the Substance Use Trajectory (R61/R33 Clinical Trial Optional)
- RFA-DA-23-029: NIDA REI: Research at Minority Serving Institutions on Neurocognitive Mechanisms Underlying the Impact of Structural Racism on the Substance Use Trajectory (R61/R33 Clinical Trial Optional)
- RFA-DA-23-031: NIDA REI: Racial Equity Visionary Award Program for Research at Minority Serving Institutions on Substance Use and Racial Equity (DP1 Clinical Trial Optional)
- RFA-AI-22-057: Transplantation Statistical and Clinical Coordinating Center (T-SCCC) (U01 Clinical Trial Not Allowed)
- PAR-22-223: Identifying Host Cell Death Pathway Targets for Host-Directed Therapies for Treatment of Mtb and Mtb/HIV Co-Infection (R01 Clinical Trial Not Allowed)
- PAR-22-215: Advancing Research to Understand Congenital Malformations (R01 Clinical Trial Not Allowed)
- RFA-AG-23-020: Building Infrastructure for Precision Medicine Research on Minority Health and Disparities in Alzheimers Disease (AD) and AD-Related Dementias (ADRD) (UH2/UH3 Clinical Trial Not Allowed)
- RFA-AG-23-027: Resource Centers for Minority Aging Research (RCMAR) Coordinating Center (U24 Clinical Trial Optional)
- RFA-AG-23-025: Alzheimer's-related Resource Centers for Minority Aging Research (AD/ADRD RCMAR) (P30 Clinical Trial Optional)
- RFA-AG-23-026: Resource Centers for Minority Aging Research (RCMAR) (P30 Clinical Trial Optional)
- PAR-22-222: Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional)
- RFA-DA-23-053: HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R61/R33 Clinical Trial Optional)
- RFA-DA-23-054: HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R33 Clinical Trial Optional)
- RFA-HD-23-009: NICHD Global Network for Womens and Childrens Health Research: Data Coordinating Center (U24 Clinical Trial Optional)
- RFA-HD-23-008: NICHD Global Network for Womens and Childrens Health Research: Research Units (UG1 Clinical Trial Optional)
- RFA-DE-23-015: HEAL Initiative: Oral Complications Arising from Pharmacotherapies to Treat Opioid Use Disorders (R01 Clinical Trial Not Allowed)
- RFA-DE-23-016: HEAL Initiative: Oral Complications Arising from Pharmacotherapies to Treat Opioid Use Disorders (R21 Clinical Trial Not Allowed)
- RFA-DE-23-007: Data-Driven Tools to Accelerate the Clinical Translation of Novel Dental, Oral, and Craniofacial Biomaterials (R42 Fast-Track - Clinical Trial Not Allowed)
- RFA-NS-22-059: Early-Stage Therapy Development for ADRD (R61/R33 Clinical Trial Not Allowed)
- RFA-DE-23-006: Data-Driven Tools to Accelerate the Clinical Translation of Novel Dental, Oral, and Craniofacial Biomaterials (R61/R33 - Clinical Trial Not Allowed)
- RFA-DE-23-008: Data-Driven Tools to Accelerate the Clinical Translation of Novel Dental, Oral, and Craniofacial Biomaterials (Fast-Track - R44 - Clinical Trial Not Allowed)
- RFA-CA-22-019: Global Implementation Science for Equitable Cancer Control (GlobalISE Cancer Control, U54 Clinical Trial Optional)
- RFA-OD-22-014: Specialized Centers of Research Excellence (SCORE) on Sex Differences (U54 Clinical Trial Optional)
- RFA-HD-23-029: Contraceptive Development Research Center (P50 Clinical Trial Optional)
- PAR-22-220: Postbaccalaureate Research Education Program (PREP)(R25 - Independent Clinical Trial Not Allowed)
- RFA-NS-23-003: HEAL Initiative: Interdisciplinary Team Science to Uncover the Mechanisms of Pain Relief by Medical Devices (RM1 Clinical Trial Optional)
- RFA-DK-22-002: Helping to Accelerate Research Potential (HARP) (UE5 - Clinical Trial Not Allowed)
- RFA-DA-23-049: HEAL Initiative: Therapeutics Development for Opioid Use Disorder in Patients with Co-occurring Mental Disorders (UG3/UH3 - Clinical Trial Optional)
- RFA-HD-23-027: Coordinating Center for the NICHD Population Dynamics Centers Research Infrastructure Program FY 2023 (R24 Clinical Trial Not Allowed)
- RFA-DK-22-022: Integrated Physiology of Exocrine and Endocrine Pancreas in Type 1 Diabetes (R01 - Clinical Trial Not Allowed)
- RFA-DK-22-014: Interventions that Address Structural Racism to Reduce Kidney Health Disparities - (U01 - Clinical Trial Required)
- PAR-22-214: Geroscience Course (R25 Independent Clinical Trial Not Allowed)
- RFA-DK-22-015: Interventions that Address Structural Racism to Reduce Kidney Health Disparities Research Coordinating Center (U24 - Clinical Trial Not Allowed)
- PAR-22-218: Biology of Bladder Cancer (R01 Clinical Trial Optional)
- RFA-MH-22-185: NIMH Biobehavioral Research Awards for Innovative New Scientists (NIMH BRAINS) (R01 Clinical Trial Optional)
- RFA-DA-23-048: HEAL Initiative: Research Studies to Develop and Implement Interventions to Prevent Opioid Misuse in Community Health Centers (R61/R33 Clinical Trial Required)
- PAR-22-219: Biology of Bladder Cancer (R21 Clinical Trial Optional)
- RFA-CA-22-045: NCI Outstanding Investigator Award (R35 Clinical Trial Optional)
- PAR-23-023: Cellular and Molecular Mechanisms of Prion-Like Aggregate Seeding, Propagation, and Neurotoxicity in AD/ADRD (R01 Clinical Trial Not Allowed)
- RFA-HD-23-014: PATC3H Implementation Science Network (PATC3H-IN) Coordination, Translation and Advanced Methods and Analytics Center (UM2 Clinical Trial Optional)
- RFA-HD-23-013: Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescents in Resource Constrained Settings Implementation Science Network (PATCH-IN) Clinical Research Centers (UG1 Clinical Trial Optional)
- RFA-DK-22-019: Type 1 Diabetes Mellitus Stakeholder Engagement Innovation Center to Advance Health Equity (U2C Clinical Trial Not Allowed)
- RFA-NS-23-004: Limited Competition for the Continuation of Clinical Sites for the Undiagnosed Diseases Network (U01 Clinical Trial Not Allowed)
- RFA-MH-22-240: BRAIN Initiative: Brain Behavior Quantification and Synchronization (R61/R33 Clinical Trial Optional)
- RFA-DK-22-503: Limited Competition for the Continuation of the Chronic Renal Insufficiency Cohort (CRIC) Scientific and Data Coordinating Center (U24 - Clinical Trial Not Allowed)
- RFA-AA-22-003: Early Liver Transplantation Cohort Study for Alcohol-associated Liver Diseases (Collaborative R01 Clinical Trial Not Allowed)
- RFA-NS-22-065: HEAL Initiative: Coordinated Pain Care in Health Care Systems Research Program - Coordinating Center (U24 Clinical Trial Not Allowed)
- RFA-NS-22-053: NIH HEAL Initiative: Coordinated Approaches to Pain Care in Health Care Systems (UG3/UH3 - Clinical Trial Optional)
- RFA-NS-22-055: Functional Target Validation for Alzheimer's Disease-Related Dementias (ADRDs) (R61/R33 Clinical Trial Not Allowed)
- RFA-AI-22-046: Understanding Persistent Signs and Symptoms Attributed to Post-Treatment Lyme Disease (R01 Clinical Trial Not Allowed)
- RFA-MH-22-191: Expanding Collaborative Implementation Science to Address Social and Structural Determinants of Health and Improve HIV Outcomes (R24 Clinical Trial Not Allowed)
- RFA-DK-22-502: Limited Competition for the Continuation of the Chronic Renal Insufficiency Cohort (CRIC) Clinical Centers (U01 - Clinical Trial Not Allowed)
- RFA-MH-22-190: Expanding Collaborative Implementation Science to Address Social and Structural Determinants of Health and Improve HIV Outcomes (R01 Clinical Trial Required)
- RFA-CA-22-039: The Early Detection Research Network: Clinical Validation Centers (U01 Clinical Trial Optional)
- RFA-CA-22-040: The Early Detection Research Network: Biomarker Characterization Centers (U2C Clinical Trial Not Allowed)
- PAR-22-210: Research to Action: Assessing and Addressing Community Exposures to Environmental Contaminants (R01 Clinical Trial Optional)
- RFA-DK-22-505: Limited Competition for Continuation of the Prospective Study of Chronic Kidney Disease in Children Data Coordinating Center (U24 Clinical Trial Not Allowed)
- RFA-DK-22-010: Chronic Kidney Disease in Children Central Biochemistry Laboratory (U24 Clinical Trial Not Allowed)
- RFA-DK-22-504: Limited Competition for Continuation of the Prospective Study of Chronic Kidney Disease in Children Clinical Coordinating Centers (U01 Clinical Trial Not Allowed)
- RFA-CA-22-038: Limited Competition: Cancer Immune Monitoring and Analysis Centers (CIMACs) and Cancer Immunologic Data Center (CIDC) (U24 Clinical Trial Not Allowed)
- PAS-22-207: HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K23 - Clinical Trial Required)
- RFA-DK-21-031: Mass Spectrometric Assays for the Reliable and Reproducible Detection of Proteins/Peptides of Importance in Type 1 Diabetes (T1D) Research (U01 Clinical Trial Not Allowed)
- PAR-22-216: NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)
- PAS-22-206: HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K01 - Clinical Trial Required)
- RFA-OD-22-015: Galvanizing Health Equity Through Novel and Diverse Educational Resources (GENDER) Research Education R25 (R25 Clinical Trial Not Allowed)
- RFA-TR-22-029: Basket Clinical Trials of Drugs Targeting Shared Molecular Etiologies in Multiple Rare Diseases (U44 Clinical Trial Required)
- PAR-22-203: Point-of-Care Technologies Research Network: Technology Research and Development Centers (TRDC) (U54 Clinical Trial Optional)
- RFA-DK-22-009: Human Islet Research Network - Consortium on Targeting and Regeneration (HIRN-CTAR) (U01 Clinical Trial Not Allowed)
- RFA-DK-22-016: Understanding the Pathophysiology and Clinical Course of New-Onset Diabetes Following COVID-19 (U01 Clinical Trial Not Allowed)
- RFA-DA-23-051: HEAL Initiative: Preventing Opioid Misuse and Co-Occurring Conditions by Intervening on Social Determinants (R01 - Clinical Trials Optional)
- RFA-AT-23-002: HEAL Initiative: Sickle Cell Disease Pain Management Trials Utilizing the Pain Management Effectiveness Research Network Cooperative Agreement (UG3/UH3, Clinical Trial Required)
- RFA-AT-23-001: HEAL Initiative: Pragmatic and Implementation Studies for the Management of Sickle Cell Disease Pain (UG3/UH3, Clinical Trials Optional)
- PAR-22-191: Postdoctoral Research Associate Training (PRAT) Program (Fi2)
- PAR-22-212: Institutional Research and Academic Career Development Awards (IRACDA) (K12 - Independent Clinical Trial Not Allowed)
- PAR-22-192: Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)
- PAR-22-193: Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)
- PAR-22-189: Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)
- RFA-AG-23-021: More Monitoring of Cognitive Change, Continued (M3C3) (U2C Clinical Trial Optional)
- RFA-EB-22-001: BRAIN Initiative: Transformative Brain Non-invasive Imaging Technology Development (UG3/UH3 Clinical Trial Not Allowed)
- RFA-MH-22-280: Epigenetic Mechanisms Regulating HIV CNS Latency and Neuropathogenesis Using Novel Single Cell Technologies (R01 Clinical Trial Not Allowed)
- RFA-MH-22-281: Epigenetic Mechanisms Regulating HIV CNS Latency and Neuropathogenesis Using Novel Single Cell Technologies (R21 Clinical Trial Not Allowed)
- RFA-DA-23-042: HEAL Initiative: Multilevel Interventions to Reduce Harm and Improve Quality of Life for Patients on Long Term Opioid Therapy (MIRHIQL): Resource Center (U24- Clinical Trial Optional)
- RFA-DK-22-021: Collaborative Research Using Biosamples from Type 1 Diabetes Clinical Studies (R01 - Clinical Trial Not Allowed)
- RFA-DA-23-041: HEAL Initiative: Multilevel Interventions to Reduce Harm and Improve Quality of Life for Patients on Long Term Opioid Therapy (MIRHIQL) (R01 Clinical Trial Required)
- PAR-22-190: Modern Equipment for Shared-use Biomedical Research Facilities: Advancing Research-Related Operations (R24 Clinical Trials Not Allowed)
- RFA-NS-23-014: Extracellular RNA Sequencing Research Resource for the Accelerating Medicines Partnership Parkinsons Disease (AMPPD) (R24 - Clinical Trial Not Allowed)
- RFA-DA-23-045: HEAL Initiative: Rapidly Assessing the Public Health Impact of Emerging Opioid Threats (UG1 - Clinical Trial Not Allowed)
- PAR-22-170: Building in vivo Preclinical Assays of Circuit Engagement for Application in Therapeutic Development (R01 Clinical Trial Not Allowed)
- RFA-HL-23-015: New Epidemiological Cohort Study among Asian Americans, Native Hawaiians, and Pacific Islanders (AsA-NHPI): Clinical/Community Field Centers (UG3/UH3 - Clinical Trial Not Allowed)
- RFA-HL-23-016: New Epidemiological Cohort Study among Asian Americans, Native Hawaiians, and Pacific Islanders (AsA-NHPI): Coordinating Center (U24 - Clinical Trial Not Allowed)
- PAR-22-213: Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional)
- RFA-HL-23-020: Regenerative Medicine Innovation Projects (RMIP) Clinical Trial Planning Grant (R34 - Clinical Trials Not Allowed)
- RFA-HL-23-019: Regenerative Medicine Innovation Projects (RMIP) Investigator- Initiated Studies (Collaborative U01 Clinical Trial Not Allowed)
- RFA-HL-23-017: Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UG3/UH3 Clinical Trial Required)
- PAR-22-169: Novel Assays to Address Translational Gaps in Treatment Development (UG3/UH3 Clinical Trial Optional)
- RFA-DA-23-046: HEAL Initiative: Research to Foster an Opioid Use Disorder Treatment System Patients Can Count On (RM1 - Clinical Trial Optional)
- RFA-AG-23-029: NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R43/R44 Clinical Trial Optional)
- RFA-AG-23-030: NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R41/R42 Clinical Trial Optional)
- PAR-22-209: CCRP Initiative: Countermeasures Against Chemical Threats (CounterACT) Therapeutics Discovery and Early-Stage Development (UG3/UH3 Clinical Trial Not Allowed)
- PAR-22-211: Impact of the Microbiome-Gut-Brain Axis on Alzheimer's Disease and Alzheimer's Disease-Related Dementias (R01 Clinical Trial Not Allowed)
- RFA-AG-23-017: Claude D. Pepper Older Americans Independence Centers (P30 Clinical Trial Optional)
- RFA-DE-23-009: Harnessing Technologies to Support Oral Health Promotion and Management Outside the Dental Setting (UG3/UH3 Clinical Trial Required)
- RFA-ES-22-006: New Approaches for Incorporating Genetic Diversity into Toxicity Testing (R43/R44 Clinical Trial Not Allowed)
- RFA-DK-22-007: George M. O'Brien Kidney National Resource Centers (U54 - Clinical Trial Not Allowed)
- RFA-DK-22-008: National Coordinating Center for the George M. OBrien Kidney National Resource Centers (U24 - Clinical Trial Not Allowed)
- PAR-22-171: NIDDK Central Repository Non-renewable Sample Access (X01 Clinical Trial Not Allowed)
- RFA-DA-23-018: Enabling SUD Digital Therapeutics Research to Improve Payor Adoption (R44- Clinical Trial Only)
- RFA-TR-22-030: Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed)
- PAR-22-201: NIDA Program Project Grant Applications (P01 Clinical Trial Optional)
- RFA-AR-23-001: Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) (P50 Clinical Trial Optional)
- PAR-22-208: Structural Biology of Alzheimer's Disease Related Dementias (ADRDs) Proteinopathies (R01 Clinical Trial Not Allowed)
- RFA-AI-22-050: Molecular Dynamics of HIV (R01 Clinical Trial Not Allowed)
- RFA-DA-23-017: Therapeutic Development of Psychoplastogenic Compounds for Substance Use Disorders (R43/R44 - Clinical Trials Not Allowed)
- PAR-22-173: Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)
- PAR-22-174: Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)
- RFA-AG-23-033: Transformative Artificial Intelligence and Machine Learning Based Strategies to Identify Determinants of Exceptional Health and Life Span (R21/R33 Clinical Trial Not Allowed)
- PAS-22-196: Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)
- PAS-22-197: Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)
- RFA-NS-23-001: Pragmatic Clinical Trials in Community Settings to Decrease or Prevent VCID Outcomes, Including in Populations that Experience Health Disparities (U01 Clinical Trial Required)
- RFA-AG-23-032: Network for Personalization of Diagnostic Tests for Alzheimers Disease (AD) and Alzheimers Disease-Related Dementias (ADRD) in Older Adults with Multiple Chronic Conditions (MCCs) (U24 Clinical Trial Optional)
- RFA-CA-22-026: Limited Competition: A Data Resource for Blood and Marrow Transplants and Adoptive Cellular Therapy Research (U24 Clinical Trial Not Allowed)
- PAR-22-198: Precision Approaches in Radiation Synthetic Combinations (PAIRS, R01 Clinical Trial Optional)
- PAR-22-199: Precision Approaches in Radiation Synthetic Combinations (PAIRS, R21 Clinical Trial Optional)
- RFA-DA-23-011: Registry of Medical Cannabis Use and Health Outcomes (UM1 - Clinical Trial Optional)
- PAR-22-164: Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R01 Clinical Trial Optional)
- PAR-22-165: Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R21 Clinical Trial Optional)
- RFA-DA-23-052: Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 Clinical Trial Not Allowed)
- RFA-DK-22-001: Stakeholder Engagement Innovation Center for Advancing Health Equity in Type 2 Diabetes Research (U2C - Clinical Trial Not Allowed)
- RFA-DA-23-020: Novel Drug (DDT) and Medical Device Development Tools (MDDT) to Help Expedite Creation and Regulatory Approvals of New Therapies for Substance Use Disorders (SUD) (R43/R44 Clinical Trial Optional)
- RFA-DA-23-019: Novel Drug (DDT) and Medical Device Development Tools (MDDT) to Help Expedite Creation and Regulatory Approvals of New Therapies for Substance Use Disorders (SUD) (R41/R42 Clinical Trial Optional)
- RFA-AG-23-023: Measures and Methods for Research on Family Caregivers for People Living with Alzheimers Disease and Related Dementias (AD/ADRD) (R21 Clinical Trial Not Allowed)
- RFA-AG-23-022: Measures and Methods for Research on Family Caregivers for People Living with Alzheimers Disease and Related Dementias (AD/ADRD) (R01 Clinical Trial Not Allowed)
- PAR-22-181: Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)
- RFA-DK-22-501: Limited Competition for the Continuation of HiLo: Pragmatic Trial of Higher versus Lower Serum Phosphate Targets in Patients Undergoing Hemodialysis Clinical Centers (UH3- Clinical Trial Required)
- RFA-DK-22-509: Limited Competition for the Continuation of the NIDDK Diabetic Foot Consortium - Clinical Research Units (U01 Clinical Trial Optional)
- RFA-ES-22-003: Research Coordinating Center to Support Climate Change and Health Community of Practice (U24 Clinical Trial Not Allowed)
- RFA-DK-22-006: Multidisciplinary K12 Urologic Research (KURe) Career Development Program (K12 Clinical Trial Optional)
- RFA-NS-22-051: Data Management Coordinating Center for Diagnostic Centers of Excellence (U2C Clinical Trial Not Allowed)
- PA-22-177: PHS 2022-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
- PA-22-178: PHS 2022-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)
- PA-22-179: PHS 2022-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)
- RFA-DA-23-015: Transformative Research on the Basic Mechanisms of Polysubstance use in Addiction (R01 - Clinical Trial Not Allowed)
- PA-22-176: PHS 2022-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
- PAR-22-194: NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)
- RFA-RM-22-022: Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa): Research Education Program (UE5 Clinical Trial Not Allowed)
- RFA-HD-23-004: Bioprinted Tissue Constructs for Obstetric, Gynecologic, and Pediatric Applications (R01 Clinical Trial Optional)
- RFA-RM-22-023: Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa): Partnership for Innovation Research Projects (U01 Clinical Trial Not Allowed)
- PAR-22-185: Resources Access for Preclinical Integrated Drug Development (RAPIDD) Program (X01 Clinical Trial Not Allowed)
- RFA-AI-22-038: A Multi-omics Approach to Immune Responses in HIV Vaccination and Intervention (P01 Clinical Trial Not Allowed)
- PAR-22-155: Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research (P50 Clinical Trial Optional)
- PAR-22-172: Mental Health Research Dissertation Grant to Enhance Workforce Diversity (R36 Independent Clinical Trial Not Allowed)
- PAR-22-187: NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed)
- PAR-22-188: NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed)
- RFA-NS-22-041: BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (U01 Basic Experimental Studies with Humans Required)
- RFA-DK-22-003: Promoting Organ and Tissue Donation Among Health Disparity Populations (R01 - Clinical Trial Optional)
- PAR-22-180: Maximizing Investigators' Research Award (R35 - Clinical Trial Optional)
- RFA-NS-22-067: Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies for Acute Cerebroprotection- Interventions from Small Businesses (U44 Clinical Trial Not Allowed)
- RFA-NS-22-040: BRAIN Initiative: Team-Research BRAIN Circuit Programs - TeamBCP (U19 Clinical Trial Not Allowed)
- RFA-HD-23-026: NICHD Program Project Grants for HIV Research (P01 Clinical Trial Optional)
- RFA-NS-22-039: BRAIN Initiative: Team-Research BRAIN Circuit Programs - TeamBCP (U19 Basic Experimental Studies with Humans Required)
- PAR-22-186: Transgender People: Immunity, Prevention, and Treatment of HIV and STIs (R21 Clinical Trial Not Allowed)
- RFA-NS-22-036: NINDS Interdisciplinary Team Science Grant (RM1 Clinical Trial Optional)
- RFA-MH-22-180: Expanding Prevention Strategies for Mental Disorders in Mobile Populations in Humanitarian Crises (R34 Clinical Trial Optional)
- RFA-NS-22-066: Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies For Acute Cerebroprotection- Interventions (U01 Clinical Trial Not Allowed)
- RFA-DA-23-008: Stimulants and HIV: Addressing Contemporary and Recurring Epidemics (R61/R33 - Clinical Trial Required)
- RFA-NS-22-056: Treatments for Lewy Body Dementias and Frontotemporal Dementias--Exploratory Clinical Trial (U01 Clinical Trial Required)
- PAR-22-184: Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (U01 Clinical Trial Not Allowed)
- RFA-RM-22-020: NIH Directors Transformative Research Awards (R01 Clinical Trial Optional)
- RFA-CA-22-027: Research to Understand and Address the Survivorship Needs of Individuals Living with Advanced Cancer (R01 Clinical Trial Optional)
- RFA-NS-22-071: Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- RFA-DA-23-027: Workshops on Computational and Analytical Research Methods (R25 - Clinical Trial Not Allowed)
- RFA-AI-22-034: Understanding the Clinical History of Bacterial Sexually Transmitted Infections (STI) to Accelerate Diagnostic and Vaccine Development (R01 Clinical Trial Not Allowed)
- PAR-22-105: Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
- PAR-22-109: Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
- RFA-HG-22-002: Educational Hub for Enhancing Diversity in Computational Genomics and Data Science (U24 Clinical Trials Not Allowed)
- RFA-AI-22-037: Partnerships for Development of Vaccines Against Select Enteric Pathogens (R01 Clinical Trial Not Allowed)
- PAR-22-182: Behavioral and Integrative Treatment Development Program (R01 Clinical Trial Optional)
- PAR-22-183: Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional)
- PAR-22-167: Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)
- PAR-22-160: NIDCR Small Research Grants for Oral Health Data Analysis and Statistical Methodology Development (R03 Clinical Trial Not Allowed)
- PAR-22-121: Short-term Mentored Career Enhancement Award in Dental, Oral, and Craniofacial Research for Mid-Career and Senior Investigators (K18- Independent Clinical Trial Not Allowed)
- PAR-22-106: Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)
- PAR-22-143: National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders or Alcohol Use Disorder (U01 Clinical Trial Optional)
- RFA-AG-23-024: Policy and Alzheimers Disease (AD) and Alzheimers Disease-Related Dementias (ADRD) Healthcare Disparities: Access, Utilization, and Quality (R01 Clinical Trial Not Allowed)
- RFA-HD-23-016: NICHD Maternal-Fetal Medicine Units (MFMU) Network: Clinical Centers (UG1 Clinical Trial Optional)
- RFA-HD-23-017: NICHD Maternal-Fetal Medicine Units (MFMU) Network: Data Coordinating Center (U24 Clinical Trial Optional)
- PAR-22-144: National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders or Alcohol Use Disorder (U19 Clinical Trial Optional)
- RFA-NS-22-060: Emergency Awards: HEAL Initiative: Coordinating Center for National Pain Scientists Career Development (R24 Clinical Trial Not Allowed)
- RFA-HD-23-002: NICHD Neonatal Research Network (NRN): Clinical Centers (UG1 Clinical Trial Optional)
- RFA-HD-23-001: NICHD Neonatal Research Network (NRN): Data Coordinating Center (U24 Clinical Trial Optional)
- PAR-22-146: Education Program on Translational Devices (R25 Clinical Trial Not Allowed)
- RFA-RM-22-021: NIH Directors Early Independence Awards (DP5 Clinical Trial Optional)
- RFA-AR-23-002: NIAMS Rheumatic Diseases Research Resource-based Centers (P30 - Clinical Trial Not Allowed)
- RFA-DA-23-040: Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 Clinical Trial Not Allowed)
- RFA-DA-23-012: Pathogenic Mechanisms influencing Blood Brain Barrier function in HIV and Substance Use Disorders (R01 Clinical Trial Optional)
- RFA-ES-22-004: SBIR E-Learning for HAZMAT and Emergency Response (R43/R44 Clinical Trial Not Allowed)
- RFA-MH-22-230: Understanding the role of Gut Immune dysfunction and Gut Microbiome in pathogenesis of Central Nervous System co-morbidities in people living with HIV (R21 Clinical Trial Not Allowed)
- RFA-AG-23-031: Grants for Early Medical/Surgical Specialists Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional)
- RFA-NS-22-052: HEAL Initiative: Team Research for Initial Translational Efforts in Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] (U19 Clinical Trial Not Allowed)
- PAR-22-153: Infrastructure Development Training Programs for Critical HIV Research at Low-and Middle-Income Country Institutions (G11 Clinical Trials Not Allowed)
- RFA-AG-23-019: Demonstration Projects to Promote Use of Interoperable Health Records in Clinical Research (R01 Clinical Trial Not Allowed)
- PAR-22-152: Planning Grant for Fogarty HIV Research Training Program for Low- and Middle-Income Country Institutions (D71 Clinical Trial Not Allowed)
- PAR-22-151: Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43 Clinical Trial Optional)
- RFA-AG-23-028: Neuronal Vulnerability to Proteinopathies in Alzheimers Disease and Alzheimers Disease-Related Dementias (R01 Clinical Trial Not Allowed)
- PAR-22-163: Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 - Clinical Trial Optional)
- PAR-22-166: Limited Competition: NIGMS Mature Synchrotron Resources for Structural Biology (P30 - Clinical Trial Not Allowed)
- PAR-22-142: NINDS Exploratory Clinical Trials (UG3/UH3 Clinical Trial Required)
- RFA-RM-22-024: Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed)
- RFA-AA-22-002: Comprehensive Alcohol Research Centers (P60 Clinical trial Optional)
- RFA-AA-22-001: Specialized Alcohol Research Centers (P50 Clinical trial Optional)
- RFA-AI-22-024: Limited Interaction Targeted Epidemiology: Viral Suppression (LITE-VS) (UG3/UH3 Clinical Trial Optional)
- RFA-RM-22-018: NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)
- PAR-22-162: Research Opportunities in Established Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)
- PAR-22-149: NEI Cooperative Agreement for Early-Stage Clinical Trials with Greater than Minimal Risk (U01 Clinical Trial Required)
- PAR-22-150: IDeA Clinical Research Resource Center (U24 Clinical Trial Not Allowed)
- PAR-22-131: Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Cancer and Precancerous Lesions Associated with Lethal Phenotypes (R01 Clinical Trial Optional)
- RFA-DK-22-011: Cystic Fibrosis Research and Translation Centers (P30 Clinical Trial Optional)
- RFA-RM-22-014: Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allowed)
- RFA-RM-22-015: IND-enabling Studies of Somatic Genome Editing Therapeutic Leads (U19, Clinical Trial Not allowed)
- RFA-RM-22-017: Somatic Cell Genome Editing Program Translational Coordination and Dissemination Center (TCDC) (U24 - Clinical Trial Not Allowed)
- PAR-22-136: Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional)
- RFA-RM-22-016: Platform Clinical Trials of Genome Editors in Multiple Diseases (UG3/UH3, Clinical Trial Required)
- RFA-MD-22-009: Innovative Multi-Level Approaches and Strategies to Prevent, Test and Treat HIV in Primary Care Settings in Health Disparity Populations in Geographic Hot Spots in the United States (R01 - Clinical Trial Required)
- RFA-AG-23-016: Transition to Aging Research for Predoctoral Students (F99/K00 Clinical Trial Not Allowed)
- PAR-22-147: Research Projects in Physical Sciences-Oncology (U01 Clinical Trial Optional)
- RFA-OD-22-008: Small Research Grants for Analysis, Curation, and/or Sharing of Down syndrome-related Research Data for the INCLUDE Project (R03 Clinical Trial Not Allowed)
- PAR-22-161: Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts (U01 Clinical Trial Not Allowed)
- RFA-RM-22-019: NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional)
- PAR-22-157: Alcohol Health Services Research (R34 Clinical Trial Optional)
- PAR-22-158: Alcohol Treatment and Recovery Research (R01 Clinical Trial Required)
- PAR-22-156: Alcohol Health Services Research (R01 Clinical Trial Optional)
- PAR-22-159: Alcohol Treatment and Recovery Research (R34 Clinical Trial Required)
- RFA-EY-22-001: A Community Research Resource: Characterization of the Resident Ocular Microbiome. (U24 Clinical Trial Not Allowed)
- RFA-DA-23-002: Increasing Immediate Engagement and Retention in HIV Treatment with Substance Users (R01- Clinical Trials Required)
- RFA-OD-22-011: Emergency Award: Rapid Acceleration of Diagnostics Tribal Data Repository (RADx TDR) (U24 Clinical Trial Not Allowed)
- RFA-MD-22-006: Limited Competition: Research Centers in Minority Institutions (RCMI) Clinical Research Network for Health Equity (UG3/UH3 - Clinical Trial Optional)
- RFA-DC-23-001: NIDCD Research Opportunities for New Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)
- RFA-CA-22-016: Pediatric Immunotherapy Network (PIN) (U01 Clinical Trial Optional)
- RFA-AI-22-020: Development and Optimization of Next-Generation Immunological Assays to Support Influenza Clinical Studies and Trials (UH2/UH3 Clinical Trial Not Allowed)
- PAR-22-125: National Institute of General Medical Sciences (NIGMS) Bridges to the Baccalaureate Research Training Program (T34)
- RFA-OD-22-010: Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE (R61/R33 Clinical Trial Required)
- RFA-CA-22-016: Pediatric Immunotherapy Network (PIN) (U01 Clinical Trial Optional)
- RFA-AI-22-028: Partnerships for the Development of Novel Therapeutics to Combat Select Antibiotic Resistant Bacteria and Fungi (R01 Clinical Trial Not Allowed)
- RFA-CA-22-025: SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)
- RFA-OD-22-007: INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Clinical Trial Readiness (R21 Clinical Trial Not Allowed)
- RFA-OD-22-009: Transformative Research Award for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project (R01 Clinical Trial Not Allowed)
- RFA-CA-22-020: Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional)
- PAR-22-154: Laboratories to Optimize Digital Health (R01 Clinical Trial Required)
- RFA-NS-22-038: Research Program Award (R35 Clinical Trial Optional)
- PAR-22-145: Leveraging Health Information Technology (Health IT) to Address and Reduce Health Care Disparities (R01 Clinical Trial Optional)
- RFA-AI-22-025: Enhancing HIV Reservoir Susceptibility to Elimination (R01 Clinical Trial Not Allowed)
- PAR-22-132: Implementation Research to Reduce Noncommunicable Disease (NCD) Burden in Low- and Middle-Income Countries (LMICs) and Tribal Nations During Critical Life Stages and Key Transition Periods (R01 Clinical Trial Optional)
- RFA-DA-23-021: Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid and/or Stimulants use Disorders (OUD/StUD) (R43/R44 - Clinical Trial Optional)
- RFA-CA-22-013: PDX Data Commons and Coordinating Center (PDCCC) for the PDX Development and Trial Centers Research Network (PDXNet) (U24 Clinical Trial Not Allowed)
- RFA-CA-22-012: Patient Derived Xenograft (PDX) Development and Trial Centers (PDTCs) Network (U54 Clinical Trial Not Allowed)
- RFA-CA-22-023: Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
- RFA-CA-22-021: Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional)
- RFA-CA-22-022: Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)
- RFA-CA-22-024: Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
- RFA-MD-22-008: Understanding and Addressing Misinformation among Populations that Experience Health Disparities (R01 - Clinical Trials Optional)
- RFA-MH-22-220: BRAIN Initiative: Integration and Analysis of BRAIN Initiative Data (R01 Clinical Trial Not Allowed)
- RFA-MH-22-140: Understanding Suicide Risk and Protective Factors among Black Youth (R01 Clinical Trial Not Allowed)
- RFA-MH-22-141: Understanding Suicide Risk and Protective Factors among Black Youth (R21 Clinical Trial Not Allowed)
- RFA-CA-22-017: Small Business Transition Grant For Early Career Scientists (R42 Clinical Trial Not Allowed)
- RFA-DA-23-014: Avenir Award Program for Chemistry and Pharmacology of Substance Use Disorders (DP1- Clinical Trial Not Allowed)
- PAR-22-076: Prospective Observational Comparative Effectiveness Research in Clinical Neurosciences (UG3/UH3 Clinical Trial Not Allowed)
- PAR-22-127: Focused Technology Research and Development (R01 Clinical Trial Not Allowed)
- PAR-22-126: Technology Development Research for Establishing Feasibility and Proof of Concept (R21 - Clinical Trial Not Allowed)
- PAR-22-139: Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R01 Clinical Trial Not Allowed)
- PAR-22-140: Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R21 Clinical Trial Not Allowed)
- RFA-HD-23-011: National Centers for Translational Research in Reproduction and Infertility (NCTRI) (P50) (Clinical Trial Optional)
- RFA-DK-21-033: KUH Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 - Independent Clinical Trial Not Allowed)
- RFA-DK-22-004: NIDDK Partnerships with Professional Societies to Enhance Scientific Workforce Diversity and Promote Scientific Leadership (R25 - Clinical Trial Not Allowed)
- PAR-22-134: NIAID Research Education Program (R25 Clinical Trial Not Allowed)
- PAR-22-137: Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R01-Clinical Trial Not Allowed)
- PAR-22-138: Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R21-Clinical Trial Not Allowed)
- RFA-DA-23-004: Single Cell Opioid Responses in the Context of HIV (SCORCH) Program Expansion: CNS Data Generation for Chronic Opioid, Methamphetamine, Cocaine and/or Cannabinoid Exposures (U01 - Clinical Trial Not Allowed)
- PAR-22-141: NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed)
- RFA-HL-23-007: Limited Competition: Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38 Clinical Trial Not Allowed)
- RFA-LM-22-001: Short-Term Research Education Experiences to Attract Talented Students to Biomedical Informatics/Data Science Careers and Enhance Diversity (R25 Clinical Trial Not Allowed)
- RFA-DA-23-009: Enhancing Social Connectedness and Ameliorating Loneliness to Prevent and Treat SUD and Support Recovery (R21 - Clinical Trial Not Allowed)
- RFA-DA-23-010: Enhancing Social Connectedness and Ameliorating Loneliness to Prevent and Treat SUD and Support Recovery (R34 - Clinical Trial Optional)
- PAR-22-133: NIDA Research Center of Excellence Grant Program (P50 Clinical Trial Optional)
- RFA-AI-22-019: Emergency Awards: Biocontainment Facility Improvements and Building System Upgrades to Support Pandemic Preparedness (G20 Clinical Trial Not Allowed)
- PAR-22-104: Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) (D43 Clinical Trial Optional)
- RFA-MH-22-200: Addressing Mental Health Disparities Research Gaps: Aggregating and Mining Existing Data Sets for Secondary Analyses (R01 Clinical Trial Not Allowed)
- RFA-AI-22-022: Development of HIV Broadly Neutralizing Antibody Susceptibility Assays (R61/R33 Clinical Trial Not Allowed)
- PAR-22-118: International Research Ethics Education and Curriculum Development Award (R25 Clinical Trial Not Allowed)
- PAR-22-130: NIA Program Project Applications (P01 Clinical Trial Optional)
- PAR-22-116: International Bioethics Research Training Program (D43 Clinical Trial Optional)
- PAR-22-107: Centers of Excellence in Genomic Science (RM1 Clinical Trial Optional)
- RFA-CA-22-015: Cancer Control Research in Persistent Poverty Areas (U54 Clinical Trial Optional)
- PAR-22-123: Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)
- PAR-22-135: NEI Regenerative Medicine Clinical Trial Planning Grant (R34 - Clinical Trials Not Allowed)
- RFA-HD-23-007: CAPSTONE Centers for Multidisciplinary Research in Child Abuse and Neglect (P50) (Clinical Trial Optional)
- RFA-OD-22-003: Center for Coordination of Analysis, Science, Enhancement, and Logistics (CASEL) in Tobacco Regulatory Science (U54 Clinical Trial Not Allowed)
- RFA-OD-22-004: Tobacco Centers of Regulatory Science (TCORS) for Research Relevant to the Family Smoking Prevention and Tobacco Control Act (U54 Clinical Trial Optional)
- PAR-22-120: Coordinating Center to Support Research on Community Level Interventions for Firearm and Related Violence, Injury and Mortality Prevention (CLIF-VP) (U24 Clinical Trial Not Allowed)
- PAR-22-115: Research on Community Level Interventions for Firearm and Related Violence, Injury and Mortality Prevention (CLIF-VP) (UG3/UH3 Clinical Trial Optional)
- RFA-DE-23-003: Advancing HIV/AIDS Research at the Intersection of Oral and Mental Health (R21 Clinical Trial Not Allowed)
- RFA-DE-23-002: Advancing HIV/AIDS Research at the Intersection of Oral and Mental Health (R01 Clinical Trial Not Allowed)
- RFA-DK-21-505: Limited Competition for the Continuation of the Data Coordinating Center for the Diabetic Foot Consortium (U24 Clinical Trial Optional)
- PAR-22-128: NEI Clinical Research Study Planning Grant Program (R34 Clinical Trial Not Allowed)
- RFA-NS-22-028: BRAIN Initiative: Exploratory Team-Research BRAIN Circuit Programs - eTeamBCP (U01 Clinical Trials Optional)
- RFA-DE-23-010: The Role of Dentistry in the Prevention of Opioid Drug Misuse and Abuse (UG3/UH3 Clinical Trial Optional)
- RFA-AI-22-016: Improved Drug Susceptibility Testing (DST) for Tuberculosis (R01 Clinical Trial Not Allowed)
- PAR-22-119: Limited Competition: Small Grant Program for NIAMS K01, K08, K23, and K25 Recipients (R03) (Clinical Trials Not Allowed)
- PAR-22-122: Limited Competition: Clinical and Translational Science Awards (CTSA) Consortium-Wide Centers: Resources for Rapid Demonstration and Dissemination (U24 Clinical Trials Optional)
- RFA-AG-23-010: Noncoding RNAs in Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)
- RFA-AG-23-011: Noncoding RNAs in Alzheimers Disease and Related Dementias (R21 Clinical Trial Not Allowed)
- RFA-AG-23-015: Studies of Cytosolic DNAs in the Interactions of Aging Hallmarks (R01 Clinical Trial Not Allowed)
- RFA-AG-23-013: Mapping Interconnectivity Among Hallmarks of Aging under Lifespan Modifications (R01 Clinical Trial Not Allowed)
- RFA-AG-23-012: Inter-Organelle Communication as a Platform to Interrogate the Interactions of Hallmarks of Aging (R01 Clinical Trial Not Allowed)
- PAR-22-114: Administrative Supplements to Support Cancer Disparity Collaborative Research (Clinical Trial Optional)
- RFA-DA-23-006: Implementing Comprehensive HIV services in Syringe Service Program (SSP) Settings (R01 - Clinical Trial Required)
- RFA-DA-23-007: Implementing Comprehensive HIV services in Syringe Service Program (SSP) Settings (R34 - Clinical Trial Required)
- RFA-AI-22-012: Immune Drivers of Autoimmune Disease (IDAD) (U01 Clinical Trial Not Allowed)
- RFA-AG-23-007: Screening for Cognitive Impairment: Decision-Making (U24 Clinical Trial Optional)
- PAR-22-089: Development of Biomarkers or Biomarker Signatures for Neurological and Neuromuscular Disorders (R61/R33 Clinical Trial Optional)
- RFA-HL-23-018: Maximizing the Scientific Value of the NHLBI Biologic Biospecimen Repository: Scientific Opportunities for Exploratory Research (R21)
- RFA-AI-22-010: Partnerships for Rapid Diagnostics and Phenotypic Antibacterial Susceptibility Testing for Bacteremia or Hospital Acquired Pneumonia (R01 Clinical Trial Not Allowed)
- RFA-RM-22-011: Somatic Mosaicism across Human Tissues (SMaHT) Program: Tool Development Projects (UG3/UH3 Clinical Trial Not Allowed)
- RFA-RM-22-009: Somatic Mosaicism across Human Tissues (SMaHT) Program: Organizational Center (U24 Clinical Trial Not Allowed)
- RFA-RM-22-010: Somatic Mosaicism across Human Tissues (SMaHT) Program: Data Analysis Center (UM1 Clinical Trial Not Allowed)
- RFA-RM-22-012: Somatic Mosaicism across Human Tissues (SMaHT) Program: Tissue Procurement Center (U24 Clinical Trial Not Allowed)
- RFA-RM-22-013: Somatic Mosaicism across Human Tissues (SMaHT) Program: Genome Characterization Centers (UM1 Clinical Trial Not Allowed)
- RFA-AG-23-014: Mechanisms of Brain Hypoperfusion in AD/ADRD (R01 Clinical Trial Not Allowed)
- RFA-NS-22-048: BRAIN Initiative Connectivity across Scales (BRAIN CONNECTS): Comprehensive Centers for Mouse Brain (UM1 Clinical Trial Not Allowed)
- PAR-22-000: Team-Based Design in Biomedical Engineering Education (R25 Clinical Trial Not Allowed)
- RFA-NS-22-047: BRAIN Initiative Connectivity across Scales (BRAIN CONNECTS): Comprehensive Centers for Human and Non-Human Primate Brain (UM1 Clinical Trial Not Allowed)
- RFA-NS-22-049: BRAIN Initiative Connectivity across Scales (BRAIN CONNECTS): Specialized Projects for Scalable Technologies (U01 Clinical Trial Not Allowed)
- RFA-RM-22-001: Limited Competition: Transformative Research to Address Health Disparities and Advance Health Equity at Minority Serving Institutions (U01 Clinical Trial Optional)
- PAR-22-085: Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R01 Clinical Trial Not Allowed)
- PAR-22-086: Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R21 Clinical Trial Not Allowed)
- RFA-OD-22-006: Emergency Award: RADx-UP Community-Engaged Research on Rapid SARS-CoV-2 Testing among Underserved and Vulnerable Populations (U01 Clinical Trial Optional)
- RFA-OD-22-005: Emergency Awards: RADx-UP - Social, Ethical, and Behavioral Implications (SEBI) Research on Disparities in COVID-19 Testing among Underserved and Vulnerable Populations (U01 Clinical Trial Optional)
- RFA-RM-22-008: NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Cohort (U54 Clinical Trial Optional)
- RFA-AG-23-005: Health Equity and the Cost of Novel Treatments for Alzheimers Disease and Related Dementias (R61/R33 Clinical Trial Not Allowed)
- RFA-DE-23-005: In utero Treatments of Congenital Dental and Craniofacial Disorders Using Precision Medicine Approaches (R21 Clinical Trial Not Allowed)
- RFA-DE-23-004: In utero Treatments of Congenital Dental and Craniofacial Disorders Using Precision Medicine Approaches (R01 Clinical Trial Not Allowed)
- RFA-NS-22-020: Data Management and Coordinating Center (DMCC) for the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Collaborative Research Centers (CRC) (U24 Basic Experimental Studies with Humans Required)
- RFA-NS-22-019: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Collaborative Research Centers (CRCs) (U54, Basic Experimental Studies Involving Humans Allowed)
- PAR-22-117: Limited Competition: NEI - DOD Vision Research Collaborative (R01 Clinical Trial Optional)
- PAR-22-050: NIDCR Mentored Career Development Award to Promote Diversity (K01 Independent Clinical Trial Not Allowed)
- PAR-22-051: NIDCR Mentored Career Development Award to Promote Diversity (K01 Clinical Trial Required)
- PAR-22-052: NIDCR Mentored Career Development Award to Promote Diversity (K01 Independent Basic Experimental Studies with Humans Required)
- RFA-DA-23-003: Investigating Transposable Elements and Mobile DNA as Targets of Integration for Establishing HIV Reservoirs in the Brain (R61/R33 - Clinical Trial Optional)
- RFA-DC-23-002: NIDCD National Human Ear Resource Network (U24 Clinical Trial Not Allowed)
- RFA-NS-22-035: Limited Competition: NIH Neuroscience Doctoral Readiness Program (DR. Program) (R25 Clinical Trial Not Allowed)
- RFA-MH-22-130: Integrating Mental Health Care into Health Care Systems in Low- and Middle-Income Countries (R01 Clinical Trial Optional)
- RFA-NS-22-026: BRAIN Initiative: Targeted BRAIN Circuits Projects- TargetedBCP (R01 Clinical Trial Not Allowed)
- RFA-NS-22-027: BRAIN Initiative: Targeted BRAIN Circuits Planning Projects TargetedBCPP (R34 Clinical Trials Not Allowed)
- RFA-CA-22-014: Data, Evaluation and Coordinating Center for: A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials (CUSP2CT) (U24 Clinical Trial Not Allowed)
- RFA-AI-22-015: Biomarker Signatures of TB Infection in Young Children With and Without HIV (R01 Clinical Trial Not Allowed)
- RFA-NS-22-050: HEAL Initiative: Discovery of Biomarkers and Biomarker Signatures to Facilitate Clinical Trials for Pain Therapeutics (UG3/UH3 Clinical Trial Optional)
- PAR-22-098: Global Brain and Nervous System Disorders Research Across the Lifespan (R21 Clinical Trial Optional)
- PAR-22-097: Global Brain and Nervous System Disorders Research Across the Lifespan (R01 Clinical Trials Optional)
- RFA-DE-23-001: NIDCR Dental Specialty and PhD Program (K12 Clinical Trial Not Allowed)
- RFA-NS-22-018: HEAL Initiative: Discovery and Functional Evaluation of Human Pain-associated Genes and Cells (U19 Clinical Trial Not Allowed)
- RFA-NS-22-021: HEAL Initiative: Human Pain-associated Genes and Cells Data Coordination and Integration Center (U24 Clinical Trial Not Allowed)
- PAR-22-111: Early-Stage Preclinical Validation of Therapeutic Leads for Diseases of Interest to the NIDDK (R01 Clinical Trial Not Allowed)
- PAR-22-100: Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R03 Clinical Trial Not Allowed)
- PAR-22-101: Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)
- PAR-22-110: NIA Renewal and Revision Cooperative Agreements in AD/ADRD Research (U24 Clinical Trial Not Allowed)
- PAR-22-082: Innovative Pilot Mental Health Services Research Not Involving Clinical Trials (R34 Clinical Trial Not Allowed)
- PAR-22-112: Urgent Award: COVID-19 Mental Health Research (R01 Clinical Trial Required)
- PAR-22-113: Urgent Award: COVID-19 Mental Health Research (R01 Clinical Trial Optional)
- RFA-HD-23-006: Integrative Research in Gynecologic Health (R01 Clinical Trial Optional)
- PAR-22-095: NHGRI Short Courses for Genomics-Related Research Education (R25 Clinical Trial Not Allowed)
- PAR-22-078: Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional)
- RFA-NR-22-002: Advancing Integrated Models (AIM) of Care to Improve Maternal Health Outcomes among Women Who Experience Persistent Disparities (R01 Clinical Trial Required)
- RFA-NR-22-003: Advancing Integrated Models (AIM) of Care to Improve Maternal Health Outcomes among Women Who Experience Persistent Disparities (R21 Clinical Trial Optional)
- RFA-MH-22-115: BRAIN Initiative: Development of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in Human and Non-Human Primate Brain (UG3/UH3 Clinical Trial Optional)
- RFA-NR-22-001: Evaluating the Impact of COVID-19 Pandemic-related Food and Housing Policies and Programs on Health Outcomes in Health Disparity Populations (R01 Clinical Trial Optional)
- RFA-HL-23-010: Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)
- RFA-HL-23-011: Catalyze: Product Definition for Small Molecules and Biologics - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)
- RFA-MH-22-155: NIMH Instrumentation Program (S10 Clinical Trial Not Allowed)
- RFA-HL-23-014: Catalyze: Product Definition Device Prototype Testing and Design Modification, Diagnostic Disease Target Assay Development and Design Characterization, and Research Tool Testing and Validation (R33 - Clinical Trials Not Allowed)
- RFA-HL-23-012: Catalyze: Product Definition for Small Molecules and Biologics - Preliminary Product/Lead Series Identification (R33 - Clinical Trial Not Allowed)
- RFA-HL-23-013: Catalyze: Product Definition Device Prototype Design and Testing, Diagnostic Disease Target Identification and Assay Development, and Research Tool Development (R61/R33 - Clinical Trial Not Allowed)
- PAR-22-102: Investigational New Drug (IND)-enabling and Early-Stage Development of Medications to Treat Alcohol Use disorder and Alcohol-Associated Organ Damage (U43/U44 Clinical Trial Optional)
- RFA-HD-22-024: Community Engaged Research on Pregnancy Related and Associated Infections and Sepsis Morbidity and Mortality (UG3/UH3 Clinical Trial Optional)
- PAR-22-084: Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 Clinical Trial Not Allowed)
- PAR-22-103: Investigational New Drug (IND)-enabling and Early-Stage Development of Medications to Treat Alcohol Use disorder and Alcohol-Associated Organ Damage (UT1/UT2 Clinical Trial Optional)
- PAR-22-083: Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R01 Clinical Trial Not Allowed)
- RFA-ES-22-002: Revolutionizing Innovative, Visionary Environmental Health Research (RIVER) (R35 Clinical Trial Optional)
- PAR-22-058: Emergency Awards: HEAL Initiative: Translational Science Career Enhancement Awards for Early and Mid-career Investigators (K18 Clinical Trials Not Allowed)
- RFA-DE-22-011: HEAL Initiative: Secondary Analysis and Integration of Existing Data Related to Acute and Chronic Pain Development or Management in Humans (R21 Clinical Trials Not Allowed)
- PAR-22-099: Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional)
- RFA-MH-22-145: BRAIN Initiative: Standards to Define Experiments Related to the BRAIN Initiative (R01 Clinical Trial Not Allowed)
- RFA-MH-22-175: Emergency Award HEAL Initiative: Optimizing Existing Evidence-Based Multi-Component Service Delivery Interventions for People with Opioid Use Disorder, Co-Occurring Conditions, and/or Suicide Risk (R01 Clinical Trials Optional)
- RFA-MH-22-176: Emergency Award HEAL Initiative: Developing and Optimizing Multi-Component Service Delivery Interventions for People with Opioid Use Disorder, Co-Occurring Conditions, and/or Suicide Risk (R01 Clinical Trials Optional)
- RFA-DK-22-005: Advancing Research on Mechanisms and Management of Pain for Diseases and Conditions within NIDDK Mission Areas (R01 Clinical Trial Optional)
- RFA-HL-23-001: ARDS, Pneumonia, and Sepsis Phenotyping Consortium Clinical Centers (U01 Clinical Trial Not Allowed)
- RFA-HL-23-002: ARDS, Pneumonia, and Sepsis Phenotyping Consortium Coordinating Center (U01 Clinical Trial Not Allowed)
- RFA-NS-22-037: HEAL Initiative: Advancing Health Equity in Pain and Comorbidities (R61/R33 Clinical Trial Required)
- RFA-TR-22-011: Emergency Awards: HEAL Initiative-Early-Stage Discovery of New Pain and Opioid Use Disorder Targets Within the Understudied Druggable Proteome (R21 Clinical Trial Not Allowed)
- PAR-22-075: NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed)
- RFA-MD-22-007: Community Level Interventions to Improve Minority Health and Reduce Health Disparities (R01 Clinical Trial Optional)
- RFA-HG-22-004: Genome Research Experiences to Attract Talented Undergraduates into Genomic Fields to Enhance Diversity (R25 Clinical Trial Not Allowed)
- RFA-TR-22-013: Emergency Awards: HEAL Initiative- New Innovator Award (DP2 Clinical Trial Not Allowed)
- RFA-TR-22-012: Emergency Awards: HEAL Initiative-Limited Competition: HEAL Initiative Resource Centers for the Pain Management Effectiveness Research Network (ERN) (U24 Clinical Trial Not Allowed)
- RFA-HL-23-006: Stimulating Access to Research in Residency (StARR) (R38)
- RFA-AI-22-002: Nonhuman Primate Transplantation Tolerance Cooperative Study Group (U01 Clinical Trial Not Allowed)
- RFA-MH-22-110: Scalable and Systematic Neurobiology of Psychiatric and Neurodevelopmental Disorder Risk Genes: Data Resource and Administrative Coordination Center (U24 Clinical Trial Not Allowed)
- RFA-MH-22-111: Scalable and Systematic Neurobiology of Psychiatric and Neurodevelopmental Disorder Risk Genes: Assay and Data Generation Centers (RM1 Clinical Trial Not Allowed)
- RFA-AI-22-003: Nonhuman Primate Transplantation Tolerance Cooperative Study Group (U19 Clinical Trial Not Allowed)
- PAR-22-091: Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)
- PAR-22-090: Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)
- RFA-NS-22-045: HEAL Initiative: National K12 Clinical Pain Career Development Program (K12 Clinical Trial Not Allowed)
- PAR-21-360: Pilot Studies for the Spectrum of Alzheimers Disease/Alzheimers Disease-Related Dementias and Age-Related Cognitive Decline (R61 Clinical Trial Optional)
- PAR-21-357: Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required)
- RFA-DA-22-037: Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional)
- RFA-NS-22-046: HEAL Initiative: Coordinating Center for National Pain Scientists Career Development (R24 Clinical Trial Not Allowed)
- PAR-21-359: Early and Late Stage Clinical Trials for the Spectrum of Alzheimers Disease/Alzheimers Related Dementias and Age-Related Cognitive Decline (R01 Clinical Trial Optional)
- RFA-AR-22-009: HEAL Initiative: Restoring Joint Health and Function to Reduce Pain Consortium (RE-JOIN) (UC2 Clinical Trial Not Allowed)
- PAR-22-092: Health Care Models for Persons with Multiple Chronic Conditions from Populations that Experience Health Disparities: Advancing Health Care towards Health Equity (R01 - Clinical Trials Optional)
- RFA-DA-22-038: Accelerating the Pace of Drug Abuse Research Using Existing Data (R21 Clinical Trial Optional)
- PAR-22-060: Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)
- PAR-22-043: NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00 Basic Experimental Studies Involving Humans Required)
- PAR-22-041: NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed)
- PAR-22-044: NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22 Clinical Trial Not Allowed)
- PAR-22-042: NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00 Clinical Trial Required)
- PAR-22-045: NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22 Clinical Trial Required)
- PAR-22-046: NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22 Basic Experimental Studies Involving Humans Required)
- RFA-AI-22-001: Host Immunity and Novel Immunization Strategies for Clostridioides difficile Infection (CDI) (U19 Clinical Trial Not Allowed)
- PAR-22-362: NIA Renewal and Competing Revision Cooperative Agreements in Aging Research (U01 Clinical Trial Optional)
- RFA-NS-22-034: HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed)
- PAR-22-080: Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed)
- PAR-22-081: Limited Competition: Basic Instrumentation Grant (BIG) Program (S10 Clinical Trial Not Allowed)
- PAR-22-079: High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed)
- RFA-NS-22-032: Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies For Acute Cerebroprotection- Interventions (U01 Clinical Trial Not Allowed)
- RFA-NS-22-003: Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies for Acute Cerebroprotection - Testing Laboratories (U01 Clinical Trial Not Allowed)
- PAR-22-057: Emergency Awards: HEAL Initiative: Translational Science Career Enhancement Awards for Early and Mid-career Investigators (K18 Clinical Trials Not Allowed)
- RFA-AG-23-006: Coordinating Center for the Claude D. Pepper Older Americans Independence Centers (OAICs) (U24 Clinical Trial Optional)
- RFA-NS-22-004: Limited Competition: Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies for Acute Cerebroprotection - Coordinating Center (U24 Clinical Trial Not Allowed)
- RFA-NS-22-033: Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies for Acute Cerebroprotection- Interventions from Small Businesses (U44 Clinical Trial Not Allowed)
- PAR-21-363: Limited Competition: Development and Renovation of Housing, Breeding, and Research Spaces for Existing NIH-supported NHP Colonies (C06 Clinical Trial Not Allowed)
- RFA-AG-23-008: Pharmacokinetic and Pharmacodynamic (PK/PD) Studies of mTOR Inhibitors on Aging-Related Indications (U01 Clinical Trial Required)
- RFA-MD-22-003: Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional)
- RFA-MD-22-004: Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional)
- RFA-HL-23-003: Physician Scientist Transition to Independence in Blood Science Research (R00 - Clinical Trial Optional)
- RFA-DK-21-036: Elucidating the heterogeneity of impaired awareness of hypoglycemia in Type 1 Diabetes (T1D) - Biostatistics Research Center (U01 Clinical Trial Not Allowed)
- PAR-22-088: Biomedical Research Facilities (C06 Clinical Trial Not Allowed)
- RFA-DK-21-020: Elucidating the heterogeneity of impaired awareness of hypoglycemia in Type 1 Diabetes (T1D) Clinical Centers (U01 Clinical Trial Required)
- RFA-DA-22-049: HEAL Initiative: HEAL Data2Action Modeling and Economic Resource Center (U24 Clinical Trial Optional)
- RFA-DA-22-051: HEAL Initiative: HEAL Data2Action Innovation Projects (R61/R33 Clinical Trial Optional)
- RFA-MH-22-170: Advancing communication strategies to support future HIV vaccine use (R01 Clinical Trial Optional)
- RFA-CA-22-005: Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional)
- RFA-CA-22-006: Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional)
- RFA-CA-22-007: Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trials Optional)
- RFA-CA-22-008: Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional)
- RFA-CA-22-008: Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional)
- RFA-CA-22-010: Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional)
- RFA-ES-22-001: Maintaining and Enriching Environmental Epidemiology Cohorts to Support Scientific and Workforce Diversity (U24 Clinical Trial Not Allowed)
- RFA-DA-22-050: HEAL Initiative: HEAL Data2Action Research Adoption Support Center (U2C Clinical Trial Optional)
- RFA-DA-22-052: HEAL Initiative: HEAL Data2Action (HD2A) Data Infrastructure Support Center (U24 Clinical Trial Optional)
- RFA-MH-22-171: Advancing communication strategies to support future HIV vaccine use (R21 Clinical Trial Optional)
- RFA-CA-22-009: Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional)
- RFA-CA-22-011: U.S. and Low- and Middle-Income Country (LMIC) HIV-Associated Malignancy Research Centers (U54 Clinical Trial Optional)